Related references
Note: Only part of the references are listed.Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population
Carlo Selmi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
High prevalence of inherited thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries: Comparison with cryptogenic stroke
Konrad Stepien et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
Peter M. Bothwell et al.
LANCET (2018)
The effect of publication bias magnitude and direction on the certainty in evidence
Mohammad Hassan Murad et al.
BMJ EVIDENCE-BASED MEDICINE (2018)
Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity
C. M. Yelnik et al.
LUPUS (2017)
Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study
R. Hisada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria
Rosalia Demetrio Pablo et al.
MEDICINA CLINICA (2017)
Serological evolution in women with positive antiphospholipid antibodies
Leyre Riancho-Zarrabeitia et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review
O. Amengual et al.
LUPUS (2015)
The global anti-phospholipid syndrome score in primary APS
Savino Sciascia et al.
RHEUMATOLOGY (2015)
Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study
P. Mustonen et al.
LUPUS (2014)
Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)
Maria J. Cuadrado et al.
RHEUMATOLOGY (2014)
Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative
Emmanuel Coloma Bazan et al.
IMMUNOLOGIC RESEARCH (2013)
Treatment of 139 Pregnancies in Antiphospholipid-positive Women Not Fulfilling Criteria for Antiphospholipid Syndrome: A Retrospective Study
Teresa Del Ross et al.
JOURNAL OF RHEUMATOLOGY (2013)
Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes
May Ching Soh et al.
RHEUMATOLOGY (2013)
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies
Michael D. Lockshin et al.
ARTHRITIS AND RHEUMATISM (2012)
Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence
Christine A. Clark et al.
HUMAN REPRODUCTION UPDATE (2012)
Laboratory Diagnosis of the Lupus Anticoagulant
Thomas L. Ortel
CURRENT RHEUMATOLOGY REPORTS (2012)
Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study
Amelia Ruffatti et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Risk Scale for the diagnosis of antiphospholipid syndrome
Savino Sciascia et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
Vittorio Pengo et al.
BLOOD (2011)
Pathogenesis of antiphospholipid syndrome: understanding the antibodies
Pier Luigi Meroni et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies
C. Chauleur et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study
A. Ruffatti et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients
T. Hereng et al.
LUPUS (2008)
Anticoagulation treatment withdrawal in primary antiphospholipid syndrome when anticardiolipin antibodies become negative
J. Criado-Garcia et al.
REVISTA CLINICA ESPANOLA (2008)
A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies
Guillermo Ruiz-Irastorza et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome - A randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals
Doruk Erkan et al.
ARTHRITIS AND RHEUMATISM (2007)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
A prospective study of antibodies to β2-glycoprotein I and prothrombin, and risk of thrombosis
R Forastiero et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant - art. no. CD002859.pub2
M Empson et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Share Paper
